CCAR2 and colorectal cancer: In spite of this deletion assignment, further studies showed DBC1 overexpression in breast, esophageal, gastric and colorectal cancers (17–21) and loss of DBC1 increases the death of breast cancer cells (22,23); however, DBC1 inhibits cancer cell survival following genotoxic stress (24,25).